Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
November 29, 2022
Featuring senior research analyst Keay Nakae, CFA.
Investor's Business Daily | Read more ›
Thank You!
We've received your information, and we're processing your request.
Get In Touch.
All fields required